Follicle-stimulating hormone receptor (FSHR) is expressed on up to 70% of ovarian cancers of various subtypes, but is absent on non-ovarian healthy tissue [140] (RNA data only available at Protein Atlas; https://www.proteinatlas.org/ENSG00000170820-FSHR/tissue, accessed on 9 January 2023). Here, FSHR is linked to ovarian cancer.